Depression and Anxiety Trial, Recruiting NCT05830266 Sponsor: Tilburg University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05830266
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 or older who are pregnant
  • Women who attend their first pregnancy check-up before 12 weeks of pregnancy
  • Women who score above a certain level on mental health questionnaires measuring depression, anxiety, and/or parenting stress, assessed at 8 to 10 weeks after giving birth
  • Women who speak Dutch or are able to understand Dutch

Who may not be able to join:

  • Women who are pregnant with twins or a higher number of babies
  • Women who had a known hormone-related condition (such as Type 1 diabetes or Rheumatoid arthritis) before becoming pregnant
  • Women with a serious psychiatric condition such as schizophrenia, borderline personality disorder, or bipolar disorder
  • Women who are HIV positive
  • Women with problems related to drug or alcohol addiction
  • Women who have any other medical condition that requires medication during pregnancy that could be harmful to the baby and needs close monitoring
  • Women who do not have access to the internet

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marion I van den Heuvel, PhD, Tilburg University

Phone: +31134664085

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tilburg University
Registry
ClinicalTrials.gov
Start date
1 July 2023
Est. completion
1 July 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Change from baseline postpartum depressive symptoms; Change from baseline postpartum anxiety symptoms; Change from baseline parental stress; Change from baseline mother-infant bonding; Change from baseline neural synchrony between mother and infant (EEG outcome 1); Change from baseline neural synchrony between mother and infant (EEG outcome 2)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov